http://www.unboundmedicine.com/medline/ebm/research/alfuzosinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925762/full_citation/Use_of_alfuzosin_for_expulsion_of_stones_in_the_distal_third_of_ureter_García Morúa A, Gutiérrez García JD, Martínez Montelongo R, et al. 
Use of alfuzosin for expulsion of stones in the distal third of ureter. [JOURNAL ARTICLE]
Actas Urol Esp 2009 Oct; 33(9):1005-1010.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891715/full_citation/An_open_non_comparative_multicentre_study_on_the_impact_of_alfuzosin_on_sexual_function_using_the_Male_Sexual_Health_Questionnaire_in_patients_with_benign_prostate_hyperplasia_Kim MK, Cheon J, Lee KS, et al. 
An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19828383/full_citation/Direct_injection_liquid_chromatography/positive_ion_electrospray_ionization_mass_spectrometric_quantification_of_methotrexate_folinic_acid_folic_acid_and_ondansetron_in_human_serum_Koufopantelis P, Georgakakou S, Kazanis M, et al. 
Direct injection liquid chromatography/positive ion electrospray ionization mass spectrometric quantification of methotrexate, folinic acid, folic acid and ondansetron in human serum. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Oct 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821385/full_citation/Alpha_blockers_prior_to_removal_of_a_catheter_for_acute_urinary_retention_in_adult_men_Zeif HJ, Subramonian K 
Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. [Journal Article]
Cochrane Database Syst Rev 2009; (4):CD006744.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19814699/full_citation/The_Effects_of_Tolterodine_Extended_Release_and_Alfuzosin_for_the_Treatment_of_Double_J_Stent_Related_Symptoms_Park SC, Jung SW, Lee JW, et al. 
The Effects of Tolterodine Extended Release and Alfuzosin for the Treatment of Double-J Stent-Related Symptoms. [JOURNAL ARTICLE]
J Endourol 2009 Oct 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19783871/full_citation/Effects_of_four_different_alpha_1__adrenoceptor_antagonists_on_alpha_adrenoceptor_agonist_induced_contractions_in_isolated_mouse_and_hamster_ureters_Kobayashi S, Tomiyama Y, Maruyama K, et al. 
Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters. [Journal Article]
J Smooth Muscle Res 2009 Aug; 45(4):187-95.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19691138/full_citation/Re:_Alfuzosin_and_symptoms_of_chronic_prostatitis_chronic_pelvic_pain_syndrome_Madersbacher S 
Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. [Comment, Journal Article]
Eur Urol 2009 Aug; 56(2):399.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19641358/full_citation/Alfuzosin_10_mg_once_daily_increases_the_chances_of_successful_trial_without_catheter_after_acute_urinary_retention_secondary_to_benign_prostate_hyperplasia_Tiong HY, Tibung MJ, Macalalag M, et al. 
Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. [Journal Article]
Urol Int 2009; 83(1):44-8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19626818/full_citation/Safety_and_efficacy_of_a_prolonged_release_formulation_of_alfuzosin_10_mg_once_daily_in_patients_with_lower_urinary_tract_symptoms_suggestive_of_benign_prostatic_hyperplasia_Kongkanand A, Chodchoy V, Lojanapiwat B, et al. 
Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. [Journal Article, Research Support, Non-U.S. Gov't]
J Med Assoc Thai 2009 Jul; 92(7):969-78.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19603043/full_citation/Can_open_label_studies_demonstrate_efficacy_in_improving_sexual_functionMichel MC, Meissner A 
Can open-label studies demonstrate efficacy in improving sexual function? [Comment, Letter]
Int J Impot Res 2009 Jul-Aug; 21(4):265; author reply 265-6.
Full Citation | Publisher Full Text | Find Related Articles